The Incidence of Malignancy and Autoimmune Disorders After Thymectomy: An Exploratory Study
European Journal of Cardio-Thoracic Surgery · 06.01.2026 · 68 (1)
DOI: 10.1093/ejcts/ezag018 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 07.01.2026. Verfasst von Chloe E Hanson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Swedish Medical Center, Seattle, WA 98104, United States. Hauptthemen laut MEDLINE: Thymectomy, Autoimmune Diseases, Postoperative Complications, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
Thymectomy reportedly increases the risk of cancer, autoimmune disease, and death. Studies are few and data limited. We sought to determine the incidence of postoperative malignancy and autoimmune disease in patients who underwent thymectomy.
Methods
We conducted a retrospective review of adult patients undergoing thymectomy between 2008 and 2020. Postoperative cancers and autoimmune disease were diagnosed after thymectomy. Incidence rates were calculated using patient-years and compared to the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) programme incidence of cancer for the US general population. Autoimmune disease rates were compared to previously published results.
Results
There were 226 patients with a median age of 55 years (interquartile range [IQR] = 39-67), mostly female (129, 57%) and non-smokers (132, 58%). At baseline, 117 (52%) had autoimmune disease, including 102 (45%) with myasthenia gravis. Eighty-four (37%) thymomas were identified. Median follow-up was 6.0 years (134 with >5-year follow-up and 44 with >10-year follow-up). We observed 13 (6%) new malignancies for an incidence of 0.87 cases/100 person-years (0.87%) and comparable to the NCI rate of 0.81 cases/100 person-years (0.81%). Incident cancers developed within the first 5 years after surgery at 0.92 cases/100 person-years (0.92%) or 4.6% cumulatively over 5 years, compared to NCI data at 4%. There were 19 (8%) new autoimmune diagnoses with an incidence rate of 1.3 cases/100 person-years (1.3%) and is higher than large population studies (0.7 cases/100 person-years for all ages).
Conclusions
Development of new cancers following thymectomy in the United States is similar to the general population. But we identified a higher incidence of autoimmune disease, matching prior studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Swedish Medical Center, Seattle, WA 98104, United States.
ORCID-Profile: Brian E Louie
Zitieren
APA
Hanson, C. E., White, P. T., Bograd, A. J., Mackay, E. M., Farivar, A. S., Vallières, E., & Louie, B. E. (2026). The Incidence of Malignancy and Autoimmune Disorders After Thymectomy: An Exploratory Study. European Journal of Cardio-Thoracic Surgery, 68(1). https://doi.org/10.1093/ejcts/ezag018
Vancouver
Hanson CE, White PT, Bograd AJ, Mackay EM, Farivar AS, Vallières E, et al. The Incidence of Malignancy and Autoimmune Disorders After Thymectomy: An Exploratory Study. European Journal of Cardio-Thoracic Surgery. 2026;68(1). doi:10.1093/ejcts/ezag018
BibTeX
@article{Hanson2026,
author = {Hanson, Chloe E and White, Peter T and Bograd, Adam J and Mackay, Emily M and Farivar, Alexander S and Vallières, Eric and Louie, Brian E},
title = {The Incidence of Malignancy and Autoimmune Disorders After Thymectomy: An Exploratory Study},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2026},
volume = {68},
number = {1},
doi = {10.1093/ejcts/ezag018}
}
EUVIMED